Validation of a Remote Patient Monitoring System for Parkinson Symptom Severity
Objective: To evaluate the feasibility of building a remote patient monitoring (RPM) system for measuring Parkinson symptom severity. Background: The characteristic objective measures (tremor, rigidity,…Early-phase 18F-FP-CIT PET images: a promising imaging biomarker for predicting early dementia conversion in Parkinson’s disease
Objective: This study aims to investigate whether early-phase 18F-N-(3-fluoropropyl)-2β-carboxymethoxy-3β-(4-iodophenyl) nortropane (18F-FP-CIT) positron emission tomography (PET) images (i.e., images acquired within the first 10 min after…Navigating Open Science in Canada with the Canadian Open Parkinson Network
Objective: The Canadian Open Parkinson Network (C-OPN) is a pan-Canadian initiative that bridges people, data and resources to accelerate new discoveries in the field of…The incidence of Parkinson’s disease in Nigeria: a systematic review and meta-analysis
Objective: The study aim to integrate various investigations pertaining to the incidence of Parkinson's disease (PD) in Nigeria, with the objective of comprehensively characterizing the…The pivotal role of dual tracer (FDG + DOPA) PET MRI brain for diagnosis of MSA-C.
Objective: This case report demonstrates the potential of dual-tracer imaging (FDG + DOPA) PET MRI brain in diagnosing and distinguishing the patients with MSA-C from atypical…Epigenetic clocks suggest accelerated ageing in isolated REM Sleep Behavior Disorder patients
Objective: To investigate biological aging in videopolysomnography (vPSG)-confirmed isolated REM Sleep Behavior Disorder (iRBD) patients and vPSG-negative controls, using DNA methylation-based epigenetic clocks. Background: Isolated…Ramelteon ameliorates abnormal sleep-wake behavior in a zebrafish model of Parkinson’s disease by facilitating abnormal lipid metabolism
Objective: The study aims to explore the role of melatonin receptor 1 (MT1) in the regulation of sleep-wake behavior in rotenone-induced Parkinson's disease (PD) model…Glial neurotrophiz factor as a differential marker of Parkinson`s disease and vascular parkinsonism
Objective: To analysis of glial neurotrophic factor content in blood serum of patients with PD and VP. Background: Parkinson's disease (PD) and vascular parkinsonism (VP)…Parkinson’s disease in patients with Gaucher’s disease – causation or association?
Objective: To do a systematic review to find the risk of Parkinson's disease in patients with Gaucher’s disease. Background: Parkinson's disease (PD) is the second…Predictors of cognitive deficits in patients with idiopathic normal pressure hydrocephalus – a pilot MRI volumetric study
Objective: The pilot study aimed to identify neuroanatomical predictors of cognitive performance in patients with iNPH. Background: Idiopathic normal pressure hydrocephalus (iNPH) is a specific…
- « Previous Page
- 1
- …
- 17
- 18
- 19
- 20
- 21
- …
- 388
- Next Page »